Liu, X., Shan, X., Chen, H., Li, Z., Zhao, P., Zhang, C., . . . Lu, R. (2019). Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis. Front Pharmacol.
Chicago ZitierstilLiu, Xiao, Xiaoli Shan, Huihua Chen, Zan Li, Pei Zhao, Chen Zhang, Wei Guo, Ming Xu, und Rong Lu. "Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis." Front Pharmacol 2019.
MLA ZitierstilLiu, Xiao, et al. "Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis." Front Pharmacol 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.